{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:28:18Z","timestamp":1792898898570,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI116420"],"award-info":[{"award-number":["AI116420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bmc.2024.117610","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T21:57:09Z","timestamp":1706047029000},"page":"117610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["SAR study of N\u2032-(Salicylidene)heteroarenecarbohydrazides as promising antifungal agents"],"prefix":"10.1016","volume":"100","author":[{"given":"Yi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saerom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeungYoun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel S.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lazzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupanandan","family":"Haranahalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7405-2783","authenticated-orcid":false,"given":"Julia","family":"Zambito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashna","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-1161","authenticated-orcid":false,"given":"Iwao","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117610_b0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tim.2014.01.001","article-title":"A neglected epidemic: fungal infections in HIV\/AIDS","volume":"22","author":"Armstrong-James","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmc.2024.117610_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","article-title":"Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"93","author":"Mousset","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bmc.2024.117610_b0015","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2024.117610_b0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2024.117610_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bmc.2024.117610_b0030","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging New Targets for the Treatment of Resistant Fungal Infections","volume":"61","author":"Liu","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0035","article-title":"Antifungal pharmacokinetics and pharmacodynamics","volume":"5","author":"Lepak","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bmc.2024.117610_b0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Bruggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2024.117610_b0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2024.117610_b0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2024.117610_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-199244010-00002","article-title":"Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications","volume":"44","author":"Lyman","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2024.117610_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00134-008-1338-7","article-title":"Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bmc.2024.117610_b0065","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive Aspergillosis","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2024.117610_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/2047-783X-16-4-153","article-title":"Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature","volume":"16","author":"Mayr","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.bmc.2024.117610_b0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1378\/chest.08-2859","article-title":"Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005)","volume":"136","author":"Kelley","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.bmc.2024.117610_b0080","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0924-8579(08)70013-X","article-title":"Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad Trial and other new data","volume":"32","author":"Mu\u00f1oz","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2024.117610_b0085","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at High Risk of Invasive Fungal Infections","volume":"68","author":"R\u00fcping","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2024.117610_b0090","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids","volume":"6","author":"Mor","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.bmc.2024.117610_b0095","doi-asserted-by":"crossref","first-page":"e00188","DOI":"10.1128\/mBio.00188-18","article-title":"Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids","volume":"9","author":"Mor","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.bmc.2024.117610_b0100","doi-asserted-by":"crossref","first-page":"e00156","DOI":"10.1128\/AAC.00156-18","article-title":"Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids","volume":"62","author":"Lazzarini","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117610_b0105","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/acs.jmedchem.9b01004","article-title":"SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents","volume":"62","author":"Haranahalli","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0110","doi-asserted-by":"crossref","unstructured":"Lazzarini C, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Poeta MD. Preclinical evaluation of acylhydrazone SB-AF-1002 as a novel broad-spectrum antifungal agent. Antimicrob. Agents Chemother. 2020, 64(9):e00946-20 (2020), e00946-20.","DOI":"10.1128\/AAC.00946-20"},{"key":"10.1016\/j.bmc.2024.117610_b0115","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4155\/fmc-2016-0093","article-title":"AutoQSAR: an automated machine learning tool for best-practice quantitative structure-activity relationship modeling","volume":"8","author":"Dixon","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0120","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0125","unstructured":"Schr\u00f6dinger Release 2023-2: QikProp, S., LLC, New York, NY, 2021."},{"key":"10.1016\/j.bmc.2024.117610_b0130","unstructured":"https:\/\/perkinelmerinformatics.com\/products\/research\/chemdraw."},{"key":"10.1016\/j.bmc.2024.117610_b0135","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1002\/anie.201200205","article-title":"Synthetic (+\/-)-axinellamines deficient in halogen","volume":"51","author":"Ding","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2024.117610_b0140","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acsmedchemlett.2c00405","article-title":"Fragment-Based Dynamic Combinatorial Chemistry for Identification of Selective \u03b1-Glucosidase Inhibitors","volume":"13","author":"Wu","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117610_b0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10593-015-1724-3","article-title":"Synthesis of N-and C-azolyl-substituted pyrazolo [1, 5-a] pyrimidines by recyclization of pyrimidinium salts","volume":"51","author":"Danagulyan","year":"2015","journal-title":"Chem. heterocycl. compounds"},{"key":"10.1016\/j.bmc.2024.117610_b0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1039\/C2OB26648B","article-title":"Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion","volume":"11","author":"Yeoh","year":"2013","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s42269-020-00389-7","article-title":"Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents","volume":"44","author":"Abdullahi","year":"2020","journal-title":"Bull Natl Res Cent."},{"key":"10.1016\/j.bmc.2024.117610_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminformatics"},{"key":"10.1016\/j.bmc.2024.117610_b0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2024.117610_b0170","unstructured":"Approved Standard\u2014Ninth Edition, CLSI document M07-A9. Wayne, PA: Clinical and laboratory standards institute 2012."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:49Z","timestamp":1760837089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S0968089624000245"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117610","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAR study of N\u2032-(Salicylidene)heteroarenecarbohydrazides as promising antifungal agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117610"}}